Arthur Rusovici in New York, New York

Additional Medical Specialties Include:
CARDIOVASCULAR DISEASE (CARDIOLOGY)

Medical School: Sorry, his university is not listed
Graduation Year: 2005
The Primary Medical Specialty for Arthur Rusovici is listed as: Interventional Cardiology
Approximate Years of Experience: 19
PAC (PECOS ID)#: 6901030956
NPI #: 1194966788
NPI Created On: 03/12/2009
NPI Last Updated Listed as: 03/30/2021
Primary Taxonomy Code: 207R00000X
License Number:
250098
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Catheter insertion of stents in major coronary artery or branch, accessed through the skin
3. Routine ekg using at least 12 leads including interpretation and report
4. Insertion of probe in esophagus for heart ultrasound examination including interpretation and report
5. Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
6. Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
7. Insertion of catheter in right and left heart for imaging of blood vessels or grafts and left lower heart
8. New patient office or other outpatient visit, typically 60 minutes
9. Established patient office or other outpatient, visit typically 25 minutes
10. Established patient office or other outpatient, visit typically 40 minutes
11. Initial hospital inpatient care, typically 50 minutes per day
12. Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.